Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jessica Boehmer"'
Autor:
Ana Acuña-Villaorduña, Joaquina Celebre Baranda, Jessica Boehmer, Lola Fashoyin-Aje, Steven D. Gore
Publikováno v:
American Society of Clinical Oncology Educational Book.
The mismatch between the study populations participating in oncology clinical trials and the composition of the targeted cancer population requires urgent amelioration. Regulatory requirements can mandate that trial sponsors enroll diverse study popu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f58b77ef8fad8736e0e8c074050d6b40
https://doi.org/10.1200/edbk_389838
https://doi.org/10.1200/edbk_389838
Autor:
Elizabeth S. Duke, Michael J. Fusco, Patrick DeMoss, Asma Dilawari, Gulsum E. Pamuk, Jessica Boehmer, Bronwyn Mixter, Kirsten B. Goldberg, Paul Kluetz, Richard Pazdur
Publikováno v:
Cancer discovery. 12(12)
Summary: In 2022, cancer drug development continued to progress rapidly despite the lingering COVID-19 pandemic. Highlights of U.S. drug approvals for oncology indications this year include ongoing development in rare diseases and molecular subgroups
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::681044504f1d7e86e944b462d3d805cc
https://pubmed.ncbi.nlm.nih.gov/36458428
https://pubmed.ncbi.nlm.nih.gov/36458428
Autor:
Jessica Boehmer, Mitchell Chan, Kirsten B. Goldberg, Tamy Kim, Richard Pazdur, Barbara Scepura
Publikováno v:
Oncologist
The Oncology Center of Excellence at the Food and Drug Administration (FDA) launched Project Facilitate on May 31, 2019, to assist oncology healthcare providers with Expanded Access requests for investigational drugs. Expanded Access, sometimes calle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0d68a619b4116cba8950f535e2f218d
https://europepmc.org/articles/PMC8488788/
https://europepmc.org/articles/PMC8488788/
Publikováno v:
Journal of Clinical Oncology. 40:e18556-e18556
e18556 Background: FDA Oncology Center of Excellence’s (OCE) Project Facilitate (PF) was launched in June 2019 in response to perceived barriers providers face when accessing Expanded Access (EA). Since launch, PF continues to evolve and innovate t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f3f97b2f447bfd9b647a98d1bc7dccf
https://doi.org/10.1200/jco.2022.40.16_suppl.e18556
https://doi.org/10.1200/jco.2022.40.16_suppl.e18556
Autor:
Laurent Humeau, David Berlinger, Xaobin Lu, Gwendolyn K. Binder, Vladmier Slepushkin, Michael Doub, Kathy Schonely, Reuben Cohen, Brian Davis, Li Yuexia, Karen Bengston, Jessica Boehmer, Tatiana Slepushkina, Boro Dropulic, Kris Andre, Ziping Chen
Publikováno v:
BioProcessing Journal. 2:39-47
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7dc1dbeac31d35247426312394815e71
https://doi.org/10.12665/j24.dropulic
https://doi.org/10.12665/j24.dropulic